• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用功能化多胺调节致癌 miRNA 的生物发生。

Modulation of oncogenic miRNA biogenesis using functionalized polyamines.

机构信息

Université de Bordeaux, INSERM, ARNA, 33076, Bordeaux, France.

Université Côte d'Azur, CNRS, ICN, 06107, Nice, France.

出版信息

Sci Rep. 2018 Jan 26;8(1):1667. doi: 10.1038/s41598-018-20053-5.

DOI:10.1038/s41598-018-20053-5
PMID:29374231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5786041/
Abstract

MicroRNAs are key factors in the regulation of gene expression and their deregulation has been directly linked to various pathologies such as cancer. The use of small molecules to tackle the overexpression of oncogenic miRNAs has proved its efficacy and holds the promise for therapeutic applications. Here we describe the screening of a 640-compound library and the identification of polyamine derivatives interfering with in vitro Dicer-mediated processing of the oncogenic miR-372 precursor (pre-miR-372). The most active inhibitor is a spermine-amidine conjugate that binds to the pre-miR-372 with a K of 0.15 µM, and inhibits its in vitro processing with a IC of 1.06 µM. The inhibition of miR-372 biogenesis was confirmed in gastric cancer cells overexpressing miR-372 and a specific inhibition of proliferation through de-repression of the tumor suppressor LATS2 protein, a miR-372 target, was observed. This compound modifies the expression of a small set of miRNAs and its selective biological activity has been confirmed in patient-derived ex vivo cultures of gastric carcinoma. Polyamine derivatives are promising starting materials for future studies about the inhibition of oncogenic miRNAs and, to the best of our knowledge, this is the first report about the application of functionalized polyamines as miRNAs interfering agents.

摘要

微小 RNA 是基因表达调控的关键因素,其失调与各种病理学直接相关,如癌症。使用小分子来解决致癌 miRNA 的过度表达已被证明其疗效,并为治疗应用提供了希望。在这里,我们描述了对 640 种化合物库的筛选,并鉴定了干扰体外 Dicer 介导的致癌 miR-372 前体(pre-miR-372)加工的多胺衍生物。最活跃的抑制剂是一种 spermine-amidine 缀合物,它与 pre-miR-372 的结合 K 为 0.15 μM,并以 1.06 μM 的 IC 抑制其体外加工。在过表达 miR-372 的胃癌细胞中证实了 miR-372 生物发生的抑制,并且通过解除肿瘤抑制因子 LATS2 蛋白的抑制观察到了增殖的特异性抑制,LATS2 蛋白是 miR-372 的靶标。该化合物修饰了一小部分 miRNA 的表达,并且其选择性生物活性已在胃癌患者衍生的体外培养物中得到证实。多胺衍生物是未来关于抑制致癌 miRNA 的研究的有前途的起始材料,据我们所知,这是关于功能化多胺作为 miRNA 干扰剂的应用的第一个报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/cc5615693557/41598_2018_20053_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/082cb1e7ad5f/41598_2018_20053_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/8e4f0acef35d/41598_2018_20053_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/556777d49d1e/41598_2018_20053_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/fbaf18f5052a/41598_2018_20053_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/43e1eb039d4d/41598_2018_20053_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/38ce003cd326/41598_2018_20053_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/cc5615693557/41598_2018_20053_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/082cb1e7ad5f/41598_2018_20053_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/8e4f0acef35d/41598_2018_20053_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/556777d49d1e/41598_2018_20053_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/fbaf18f5052a/41598_2018_20053_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/43e1eb039d4d/41598_2018_20053_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/38ce003cd326/41598_2018_20053_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e1e/5786041/cc5615693557/41598_2018_20053_Fig7_HTML.jpg

相似文献

1
Modulation of oncogenic miRNA biogenesis using functionalized polyamines.利用功能化多胺调节致癌 miRNA 的生物发生。
Sci Rep. 2018 Jan 26;8(1):1667. doi: 10.1038/s41598-018-20053-5.
2
Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.利用多模态合成小分子靶向致癌 microRNA 的产生。
ACS Chem Biol. 2014 Mar 21;9(3):711-21. doi: 10.1021/cb400668h. Epub 2014 Jan 3.
3
Repression of MicroRNA-372 by Arsenic Sulphide Inhibits Prostate Cancer Cell Proliferation and Migration through Regulation of large tumour suppressor kinase 2.硫化砷对MicroRNA-372的抑制作用通过调控大肿瘤抑制激酶2抑制前列腺癌细胞的增殖和迁移。
Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):256-263. doi: 10.1111/bcpt.12687. Epub 2016 Dec 28.
4
MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.微小RNA-373(miR-373)在转录后水平调控大肿瘤抑制因子同源物2(LATS2),并促进人食管癌的增殖。
Exp Cell Res. 2009 Sep 10;315(15):2529-38. doi: 10.1016/j.yexcr.2009.06.001. Epub 2009 Jun 6.
5
Building of neomycin-nucleobase-amino acid conjugates for the inhibition of oncogenic miRNAs biogenesis.构建新霉素-核苷-氨基酸缀合物以抑制致癌 miRNA 的生物发生。
Org Biomol Chem. 2018 Aug 29;16(34):6262-6274. doi: 10.1039/c8ob01858h.
6
Oncogenic miR-9 is a target of erlotinib in NSCLCs.致癌性miR-9是厄洛替尼在非小细胞肺癌中的作用靶点。
Sci Rep. 2015 Nov 23;5:17031. doi: 10.1038/srep17031.
7
Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis.pri-miRNA 三级结构在 miR-17~92 miRNA 生物发生中的作用。
RNA Biol. 2011 Nov-Dec;8(6):1105-14. doi: 10.4161/rna.8.6.17410. Epub 2011 Nov 1.
8
AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.AC1MMYR2,一种 Dicer 介导的 Oncomir miR-21 生物发生抑制剂,可逆转上皮-间充质转化,抑制肿瘤生长和进展。
Cancer Res. 2013 Sep 1;73(17):5519-31. doi: 10.1158/0008-5472.CAN-13-0280. Epub 2013 Jun 28.
9
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.微小RNA-205靶向血管内皮生长因子A(VEGFA)和成纤维细胞生长因子2(FGF2)并调节乳腺癌对化疗药物的耐药性。
Cell Death Dis. 2016 Jun 30;7(6):e2291. doi: 10.1038/cddis.2016.194.
10
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.小分子依诺沙星是一种癌症特异性生长抑制剂,通过增强 TAR RNA 结合蛋白 2 介导的 microRNA 加工起作用。
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4394-9. doi: 10.1073/pnas.1014720108. Epub 2011 Feb 28.

引用本文的文献

1
Electrostatic Anchoring in RNA-Ligand Design─Dissecting the Effects of Positive Charges on Affinity, Selectivity, Binding Kinetics, and Thermodynamics.RNA配体设计中的静电锚定——剖析正电荷对亲和力、选择性、结合动力学和热力学的影响
J Med Chem. 2025 Apr 24;68(8):8659-8678. doi: 10.1021/acs.jmedchem.5c00339. Epub 2025 Apr 7.
2
Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy.靶向微小RNA的小分子:精准癌症治疗中的新机遇与挑战
Trends Cancer. 2024 Sep;10(9):809-824. doi: 10.1016/j.trecan.2024.06.006. Epub 2024 Aug 5.
3
Targeting MicroRNAs with Small Molecules.

本文引用的文献

1
Defining RNA-Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor of an Oncogenic Noncoding RNA.定义RNA-小分子亲和力图谱有助于设计一种致癌非编码RNA的小分子抑制剂。
ACS Cent Sci. 2017 Mar 22;3(3):205-216. doi: 10.1021/acscentsci.7b00009. Epub 2017 Mar 6.
2
Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit.小分子抑制 microRNA-210 重编程致癌缺氧回路。
J Am Chem Soc. 2017 Mar 8;139(9):3446-3455. doi: 10.1021/jacs.6b11273. Epub 2017 Feb 27.
3
Click Quantitative Mass Spectrometry Identifies PIWIL3 as a Mechanistic Target of RNA Interference Activator Enoxacin in Cancer Cells.
用小分子靶向微小RNA
Noncoding RNA. 2024 Mar 14;10(2):17. doi: 10.3390/ncrna10020017.
4
Altering the Cleaving Effector in Chimeric Molecules that Target RNA Enhances Cellular Selectivity.改变靶向 RNA 的嵌合分子中的切割效应子可提高细胞选择性。
ACS Chem Biol. 2023 Nov 17;18(11):2385-2393. doi: 10.1021/acschembio.3c00363. Epub 2023 Oct 12.
5
Low-Molecular Weight Small Molecules Can Potently Bind RNA and Affect Oncogenic Pathways in Cells.低分子量小分子可以强烈结合 RNA 并影响细胞中的致癌途径。
J Am Chem Soc. 2022 Nov 16;144(45):20815-20824. doi: 10.1021/jacs.2c08770. Epub 2022 Nov 2.
6
Targeting RNA structures with small molecules.小分子靶向 RNA 结构。
Nat Rev Drug Discov. 2022 Oct;21(10):736-762. doi: 10.1038/s41573-022-00521-4. Epub 2022 Aug 8.
7
Development of 2-deoxystreptamine-nucleobase conjugates for the inhibition of oncogenic miRNA production.用于抑制致癌性微小RNA产生的2-脱氧链霉胺-核苷酸碱基缀合物的研发。
RSC Med Chem. 2021 Dec 16;13(3):311-319. doi: 10.1039/d1md00345c. eCollection 2022 Mar 23.
8
Regulating Polyamine Metabolism by miRNAs in Diabetic Cardiomyopathy.miRNAs 在糖尿病心肌病中对多胺代谢的调节作用。
Curr Diab Rep. 2021 Dec 13;21(12):52. doi: 10.1007/s11892-021-01429-w.
9
Bioinformatic Searching for Optimal RNA Targets of Dimeric Compounds Informs Design of a MicroRNA-27a Inhibitor.生物信息学搜索二聚化合物的最佳 RNA 靶点为 microRNA-27a 抑制剂的设计提供信息。
ACS Chem Biol. 2022 Jan 21;17(1):5-10. doi: 10.1021/acschembio.1c00395. Epub 2021 Dec 13.
10
The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.miRNA 在癌症中的作用:发病机制、诊断和治疗。
Methods Mol Biol. 2022;2257:375-422. doi: 10.1007/978-1-0716-1170-8_18.
点击定量质谱分析鉴定 PIWIL3 为癌症细胞中 RNA 干扰激活剂依诺沙星的作用机制靶点。
J Am Chem Soc. 2017 Feb 1;139(4):1400-1403. doi: 10.1021/jacs.6b11751. Epub 2017 Jan 23.
4
Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays.使用小分子微阵列发现微小RNA-21加工的抑制剂
ACS Chem Biol. 2017 Feb 17;12(2):435-443. doi: 10.1021/acschembio.6b00945. Epub 2016 Dec 23.
5
Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma.鉴定人胃癌肿瘤发生和化疗耐药性肿瘤干细胞的生物标志物。
Clin Cancer Res. 2017 Mar 15;23(6):1586-1597. doi: 10.1158/1078-0432.CCR-15-2157. Epub 2016 Sep 12.
6
The Emerging Role of RNA as a Therapeutic Target for Small Molecules.RNA 作为小分子治疗靶点的新兴作用。
Cell Chem Biol. 2016 Sep 22;23(9):1077-1090. doi: 10.1016/j.chembiol.2016.05.021. Epub 2016 Sep 1.
7
All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.全反式维甲酸靶向胃癌干细胞并抑制患者来源的胃癌肿瘤生长。
Oncogene. 2016 Oct 27;35(43):5619-5628. doi: 10.1038/onc.2016.87. Epub 2016 May 9.
8
Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.靶向致癌性微小RNA的小分子方法:RNA调节剂发现路线图
Future Med Chem. 2016 May;8(7):803-16. doi: 10.4155/fmc-2016-0018. Epub 2016 May 5.
9
Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates.致癌性微小RNA生物合成作为药物靶点:新型氨基糖苷类缀合物的构效关系研究
Chemistry. 2016 Apr 4;22(15):5350-62. doi: 10.1002/chem.201505094. Epub 2016 Mar 1.
10
Reprogramming carcinoma associated fibroblasts by AC1MMYR2 impedes tumor metastasis and improves chemotherapy efficacy.AC1MMYR2 重编程癌相关成纤维细胞可抑制肿瘤转移并提高化疗疗效。
Cancer Lett. 2016 Apr 28;374(1):96-106. doi: 10.1016/j.canlet.2016.02.003. Epub 2016 Feb 9.